FDA Details Plans For Quicker Approvals Of Some Individualized Gene Therapies
Rare-disease advocates applauded the draft guidance, which the FDA published Tuesday, Stat reported. Also in the news: 340B data demands, a Lyme disease vaccine candidate, and more.